$100K — $150K *
BMS’s Cell Therapy business is entering an exciting new phase as it begins the commercialization of its first CAR-T products. Commercialization drives new scope, scale, and complexity across the network and requires manufacturing sites, global organizations and IT systems to work together in new ways. This job will work with a new organization that has been established to manage this rapidly evolving environment. At the intersection of people, process, and systems, –each Global Business Process Owner owns a process segment in what we call the “arm-to-arm” process, or everything from patient enrollment until patient treatment. This includes network planning & allocation, patient apheresis & treatment, manufacturing site scheduling, manufacturing & quality operations, raw materials & procurement, logistics & order management, and master data management. This position will act as the Global Business Process Owner for the Patient Apheresis and Treatment segment. Ownership of a process segment requires leading cross-functional teams of local process owners and subject-matter experts to identify both challenges and opportunities. Once identified, this leader works with the portfolio management team to drive the prioritization and ultimate mobilization of resources necessary to deliver change. This is a mix of near-term solutions to satisfy immediate needs, and multi-year road maps to attain strategic targets.
This job reports in through BMS’s Global Patient Operations team and works closely with other process owners, Cell Therapy senior leadership, Cell Therapy subject matter experts, and IT partners. This is an exciting opportunity to shape how BMS’s Cell Therapy network operates, as well as lead cross-functionally across many parts of the Cell Therapy network.
Qualifications and Education Requirements
Valid through: 8/18/2020
$100K — $150K
21 days ago